3 exciting ASX healthcare shares to buy in May

CSL Limited (ASX:CSL) and these ASX healthcare shares could be worth considering in May. Here's why I like them…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Due to a number of positive tailwinds including increased chronic disease burden and ageing populations, I believe the healthcare sector is one of the best places to invest your money with a long term view.

And the good news is that there's no shortage of options in the space for investors to choose from.

With that in mind, here are three options in the sector to consider:

Alcidion Group Ltd (ASX: ALC)

If you're interested in small cap shares then you might want to take a look at Alcidion. It is a fast-growing health informatics company which is aiming to transform healthcare with smart, intuitive technology solutions. It has a growing portfolio of software products and services that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes.

CSL Limited (ASX: CSL)

And at the big end of the market you'll find this global biotherapeutics company. I believe CSL is the highest quality company Australia has to offer and capable of generating strong returns for investors over the long term. Especially given its leading therapies, lucrative plasma collection network, and its research and development pipeline. The latter is underpinned by high level of investment each year by the company. For example, in FY 2019 CSL invested a massive US$832 million in R&D activities across its businesses.

ResMed Inc. (ASX: RMD)

Finally, I think ResMed is another healthcare share to consider with a long term view. This medical device company has been growing at a very strong rate over the last few years thanks to its sleep treatment business. The proliferation of sleep apnoea has been driving very strong demand for both its hardware and its software. Given how many people globally are believed to be undiagnosed sufferers of sleep apnoea, I believe ResMed has a significant runway for growth. Though, with its third quarter update due to be released tomorrow, it might be prudent to wait for that before investing.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd and CSL Ltd. The Motley Fool Australia has recommended Alcidion Group Ltd and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Growth Shares

Forget PLS shares! This ASX growth stock is tipped to rise 60% by 2027

Could this beaten down stock follow PLS' lead and rebound strongly. Bell Potter thinks it could.

Read more »

2 smiling women looking at a phone.
Growth Shares

My 3 higher-risk, high-reward ASX stock recommendations for February 2026

For investors willing to accept uncertainty, selective risk can sometimes be rewarded.

Read more »

A couple and their baby sit together at their computer carrying out digital transactions and smiling happily.
Growth Shares

The bulls are coming: 2 of the best ASX growth shares to buy now to get ahead

When the bulls return, I think these shares could be in demand with investors.

Read more »

Man flies flat above city skyline with rocket strapped to back
Growth Shares

2 ASX growth stocks set to skyrocket in the next 12 months

Analysts are predicting returns of 80% to 130% from these stocks.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Growth Shares

3 underappreciated ASX growth shares I would buy with $1,000

Not all growth opportunities are obvious at first glance. These three ASX shares have earnings potential that may be underappreciated.

Read more »

US navy ship at sea.
Growth Shares

Another record in sight? Why this ASX defence stock is back in rally mode

EOS shares surge toward fresh highs as defence spending accelerates and a key South Korean contract decision looms.

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
Growth Shares

5 of the best ASX growth shares to buy and hold

Analysts are bullish on these growth shares. Let's find out why.

Read more »

A woman sends a paper plane soaring into the sky at dusk.
Growth Shares

2 ASX 200 shares to buy and hold for 10 years

Both stocks offer credible paths to wealth creation.

Read more »